Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Cited In for PubMed (Select 3094714)

1.

Fasting hyperglycemia increases in-hospital mortality risk in nondiabetic female patients with acute myocardial infarction: a retrospective study.

Luo G, Liu H, Luo S, Li F, Su M, Lu H.

Int J Endocrinol. 2014;2014:745093. doi: 10.1155/2014/745093. Epub 2014 Jul 14.

2.

Prevalence of stress hyperglycemia among hepatopancreatobiliary postoperative patients.

Shi Z, Tang S, Chen Y, Yang J, Jiang B, Liu X, Zhou X, Pan X, Yang J, Wu J, Hu H, Ji B, Lin X, Chen S, Zhang J.

Int J Clin Exp Med. 2013 Sep 25;6(9):799-803. eCollection 2013.

3.

Localization and expression of Hsp27 and αB-crystallin in rat primary myocardial cells during heat stress in vitro.

Tang S, Buriro R, Liu Z, Zhang M, Ali I, Adam A, Hartung J, Bao E.

PLoS One. 2013 Jul 19;8(7):e69066. doi: 10.1371/journal.pone.0069066. Print 2013.

4.

An elevated gap between admission and A1C-derived average glucose levels is associated with adverse outcomes in diabetic patients with pyogenic liver abscess.

Liao WI, Sheu WH, Chang WC, Hsu CW, Chen YL, Tsai SH.

PLoS One. 2013 May 28;8(5):e64476. doi: 10.1371/journal.pone.0064476. Print 2013.

5.

Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines.

Ostrowski SR, Pedersen SH, Jensen JS, Mogelvang R, Johansson PI.

Crit Care. 2013 Feb 22;17(1):R32. doi: 10.1186/cc12532.

6.

Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction.

Mapanga RF, Rajamani U, Dlamini N, Zungu-Edmondson M, Kelly-Laubscher R, Shafiullah M, Wahab A, Hasan MY, Fahim MA, Rondeau P, Bourdon E, Essop MF.

PLoS One. 2012;7(10):e47322. doi: 10.1371/journal.pone.0047322. Epub 2012 Oct 16.

7.

Glycemic variability and glycemic control in the acutely ill cardiac patient.

Moore J, Dungan K.

Heart Fail Clin. 2012 Oct;8(4):523-38. doi: 10.1016/j.hfc.2012.06.006. Epub 2012 Aug 9. Review.

8.

Insulin therapy for the management of hyperglycemia in hospitalized patients.

McDonnell ME, Umpierrez GE.

Endocrinol Metab Clin North Am. 2012 Mar;41(1):175-201. doi: 10.1016/j.ecl.2012.01.001. Epub 2012 Feb 17. Review.

9.

In-hospital death in acute coronary syndrome was related to admission glucose in men but not in women.

Takada JY, Ramos RB, Roza LC, Avakian SD, Ramires JA, Mansur Ade P.

Cardiovasc Diabetol. 2012 May 17;11:47. doi: 10.1186/1475-2840-11-47.

10.

BNP and admission glucose as in-hospital mortality predictors in non-ST elevation myocardial infarction.

Takada JY, Ramos RB, Avakian SD, dos Santos SM, Ramires JA, Mansur Ade P.

ScientificWorldJournal. 2012;2012:397915. doi: 10.1100/2012/397915. Epub 2012 Feb 1.

11.
12.

Glycemic control in non-diabetic critically ill patients.

Farrokhi F, Smiley D, Umpierrez GE.

Best Pract Res Clin Endocrinol Metab. 2011 Oct;25(5):813-24. doi: 10.1016/j.beem.2011.05.004.

13.

Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress.

Tang WH, Cheng WT, Kravtsov GM, Tong XY, Hou XY, Chung SK, Chung SS.

Am J Physiol Cell Physiol. 2010 Sep;299(3):C643-53. doi: 10.1152/ajpcell.00137.2010. Epub 2010 Jun 23.

14.

An overview of glycemic control in the coronary care unit with recommendations for clinical management.

Kosiborod M, Deedwania P.

J Diabetes Sci Technol. 2009 Nov 1;3(6):1342-51. Review.

15.

Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells.

Reddy AB, Ramana KV, Srivastava S, Bhatnagar A, Srivastava SK.

Endocrinology. 2009 Jan;150(1):63-74. doi: 10.1210/en.2008-0677. Epub 2008 Sep 4.

16.

Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome.

Weston C, Walker L, Birkhead J; National Audit of Myocardial Infarction Project, National Institute for Clinical Outcomes Research.

Heart. 2007 Dec;93(12):1542-6. Epub 2007 May 13.

17.

Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction.

van der Horst IC, Nijsten MW, Vogelzang M, Zijlstra F.

Cardiovasc Diabetol. 2007 Feb 6;6:2.

18.

Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study.

Kadri Z, Danchin N, Vaur L, Cottin Y, Guéret P, Zeller M, Lablanche JM, Blanchard D, Hanania G, Genès N, Cambou JP; USIC 2000 Investigators.

Heart. 2006 Jul;92(7):910-5. Epub 2005 Dec 9.

19.

A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes.

Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, Timmis AD.

Heart. 2003 May;89(5):512-6.

20.

Is insulin an endogenous cardioprotector?

Das UN.

Crit Care. 2002 Oct;6(5):389-93. Epub 2002 Jul 31. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk